Shopping Cart 0
Cart Subtotal
AED 0

Global Vinblastinesulphate (CAS 143-67-9) Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 12772

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 19157

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 25543

Details

Vinblastinesulphate is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-fighting medications known as antineoplastics. Vinblastine is used alone or in combination with other antineoplastic medications to treat many different types of cancer including Hodgkin's disease, non-Hodgkin's lymphoma (cancer of the lymph cells), Kaposi's sarcoma, breast cancer, and testicular cancer. It kills cancer cells by interfering with the genetic material DNA, which is necessary for their growth and reproduction.

Scope of the Report:

This report focuses on the Vinblastinesulphate (CAS 143-67-9) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Periwinkle Plantation is mainly concentrated in China. The production volume was high during 2000s, with a kilo of Vinca alkaloids can be sold at 10 USD/gram. Now as the less plantation in Hainan Province, the cost of Periwinkle and Vinca alkaloids has hiked at 20 USD/ gram. Currenly there are less companies produce Vinca alkaloids, since many companies couldn't survive after capital chain breaks. Globally, leading suppliers are Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological Medicine Technology and Guangzhou Person Pharmaceutical which are located in China. The three companies produced nealy 60% of global Vinblastinesulphate Vinkem from India also produce Vinblastinesulphate API for cancer treatment drugs.

The worldwide market for Vinblastinesulphate (CAS 143-67-9) is expected to grow at a CAGR of roughly 1.6% over the next five years, will reach 21 million USD in 2023, from 19 million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Guangzhou Hanfang Pharmaceutical

Hainan Vinca Biological Medicine Technology

Guangzhou Person Pharmaceutical

Hainan Yueyang Biotechnology

Hubei Honch Pharmaceutical

Fine Chemicals Corporation

Hengtengfu Biological Products

Vinkem

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

>98% Vinblastinesulphate

97-98% Vinblastinesulphate

Other

Market Segment by Applications, can be divided into

Lymphoma

Lung Cancer

Breast & Ovarian Cancer

Leukemia

Other

There are 15 Chapters to deeply display the global Vinblastinesulphate (CAS 143-67-9) market.

Chapter 1, to describe Vinblastinesulphate (CAS 143-67-9) Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Vinblastinesulphate (CAS 143-67-9), with sales, revenue, and price of Vinblastinesulphate (CAS 143-67-9), in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Vinblastinesulphate (CAS 143-67-9), for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Vinblastinesulphate (CAS 143-67-9) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Vinblastinesulphate (CAS 143-67-9) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Table Of Content

Scope

Table of Contents

1 Market Overview

1.1 Vinblastinesulphate (CAS 143-67-9) Introduction

1.2 Market Analysis by Type

1.2.1 >98% Vinblastinesulphate

1.2.2 97-98% Vinblastinesulphate

1.2.3 Other

1.3 Market Analysis by Applications

1.3.1 Lymphoma

1.3.2 Lung Cancer

1.3.3 Breast & Ovarian Cancer

1.3.4 Leukemia

1.3.5 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Guangzhou Hanfang Pharmaceutical

2.1.1 Business Overview

2.1.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Guangzhou Hanfang Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Hainan Vinca Biological Medicine Technology

2.2.1 Business Overview

2.2.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Hainan Vinca Biological Medicine Technology Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Guangzhou Person Pharmaceutical

2.3.1 Business Overview

2.3.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Guangzhou Person Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Hainan Yueyang Biotechnology

2.4.1 Business Overview

2.4.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Hainan Yueyang Biotechnology Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Hubei Honch Pharmaceutical

2.5.1 Business Overview

2.5.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Hubei Honch Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Fine Chemicals Corporation

2.6.1 Business Overview

2.6.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Fine Chemicals Corporation Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Hengtengfu Biological Products

2.7.1 Business Overview

2.7.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Hengtengfu Biological Products Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Vinkem

2.8.1 Business Overview

2.8.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Vinkem Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Vinblastinesulphate (CAS 143-67-9) Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Vinblastinesulphate (CAS 143-67-9) Manufacturer Market Share in 2017

3.3.2 Top 6 Vinblastinesulphate (CAS 143-67-9) Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Vinblastinesulphate (CAS 143-67-9) Market Analysis by Regions

4.1 Global Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Market Share by Regions

4.1.1 Global Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Regions (2013-2018)

4.1.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Regions (2013-2018)

4.2 North America Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

4.3 Europe Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

4.5 South America Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

5 North America Vinblastinesulphate (CAS 143-67-9) by Countries

5.1 North America Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Market Share by Countries

5.1.1 North America Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Countries (2013-2018)

5.1.2 North America Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Countries (2013-2018)

5.2 United States Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

5.3 Canada Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

5.4 Mexico Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

6 Europe Vinblastinesulphate (CAS 143-67-9) by Countries

6.1 Europe Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Market Share by Countries

6.1.1 Europe Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Countries (2013-2018)

6.2 Germany Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

6.3 UK Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

6.4 France Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

6.5 Russia Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

6.6 Italy Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

7 Asia-Pacific Vinblastinesulphate (CAS 143-67-9) by Countries

7.1 Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Countries (2013-2018)

7.2 China Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

7.3 Japan Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

7.4 Korea Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

7.5 India Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

8 South America Vinblastinesulphate (CAS 143-67-9) by Countries

8.1 South America Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Market Share by Countries

8.1.1 South America Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Countries (2013-2018)

8.1.2 South America Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

8.3 Argentina Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

8.4 Colombia Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

9 Middle East and Africa Vinblastinesulphate (CAS 143-67-9) by Countries

9.1 Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

9.3 UAE Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

9.4 Egypt Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

9.5 Nigeria Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

9.6 South Africa Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

10 Global Vinblastinesulphate (CAS 143-67-9) Market Segment by Type

10.1 Global Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Type (2013-2018)

10.1.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Type (2013-2018)

10.2 >98% Vinblastinesulphate Sales Growth and Price

10.2.1 Global >98% Vinblastinesulphate Sales Growth (2013-2018)

10.2.2 Global >98% Vinblastinesulphate Price (2013-2018)

10.3 97-98% Vinblastinesulphate Sales Growth and Price

10.3.1 Global 97-98% Vinblastinesulphate Sales Growth (2013-2018)

10.3.2 Global 97-98% Vinblastinesulphate Price (2013-2018)

10.4 Other Sales Growth and Price

10.4.1 Global Other Sales Growth (2013-2018)

10.4.2 Global Other Price (2013-2018)

11 Global Vinblastinesulphate (CAS 143-67-9) Market Segment by Application

11.1 Global Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Application (2013-2018)

11.2 Lymphoma Sales Growth (2013-2018)

11.3 Lung Cancer Sales Growth (2013-2018)

11.4 Breast & Ovarian Cancer Sales Growth (2013-2018)

11.5 Leukemia Sales Growth (2013-2018)

11.6 Other Sales Growth (2013-2018)

12 Vinblastinesulphate (CAS 143-67-9) Market Forecast (2018-2023)

12.1 Global Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Growth Rate (2018-2023)

12.2 Vinblastinesulphate (CAS 143-67-9) Market Forecast by Regions (2018-2023)

12.2.1 North America Vinblastinesulphate (CAS 143-67-9) Market Forecast (2018-2023)

12.2.2 Europe Vinblastinesulphate (CAS 143-67-9) Market Forecast (2018-2023)

12.2.3 Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Market Forecast (2018-2023)

12.2.4 South America Vinblastinesulphate (CAS 143-67-9) Market Forecast (2018-2023)

12.2.5 Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Market Forecast (2018-2023)

12.3 Vinblastinesulphate (CAS 143-67-9) Market Forecast by Type (2018-2023)

12.3.1 Global Vinblastinesulphate (CAS 143-67-9) Sales Forecast by Type (2018-2023)

12.3.2 Global Vinblastinesulphate (CAS 143-67-9) Market Share Forecast by Type (2018-2023)

12.4 Vinblastinesulphate (CAS 143-67-9) Market Forecast by Application (2018-2023)

12.4.1 Global Vinblastinesulphate (CAS 143-67-9) Sales Forecast by Application (2018-2023)

12.4.2 Global Vinblastinesulphate (CAS 143-67-9) Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Figure

List of Tables and Figures

Figure Vinblastinesulphate (CAS 143-67-9) Picture

Table Product Specifications of Vinblastinesulphate (CAS 143-67-9)

Figure Global Sales Market Share of Vinblastinesulphate (CAS 143-67-9) by Types in 2017

Table Vinblastinesulphate (CAS 143-67-9) Types for Major Manufacturers

Figure >98% Vinblastinesulphate Picture

Figure 97-98% Vinblastinesulphate Picture

Figure Other Picture

Figure Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Applications in 2017

Figure Lymphoma Picture

Figure Lung Cancer Picture

Figure Breast & Ovarian Cancer Picture

Figure Leukemia Picture

Figure Other Picture

Figure United States Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure France Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure UK Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure China Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure India Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Table Guangzhou Hanfang Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Guangzhou Hanfang Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Type and Applications

Table Guangzhou Hanfang Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Hainan Vinca Biological Medicine Technology Basic Information, Manufacturing Base and Competitors

Table Hainan Vinca Biological Medicine Technology Vinblastinesulphate (CAS 143-67-9) Type and Applications

Table Hainan Vinca Biological Medicine Technology Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Guangzhou Person Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Guangzhou Person Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Type and Applications

Table Guangzhou Person Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Hainan Yueyang Biotechnology Basic Information, Manufacturing Base and Competitors

Table Hainan Yueyang Biotechnology Vinblastinesulphate (CAS 143-67-9) Type and Applications

Table Hainan Yueyang Biotechnology Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Hubei Honch Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Hubei Honch Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Type and Applications

Table Hubei Honch Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Fine Chemicals Corporation Basic Information, Manufacturing Base and Competitors

Table Fine Chemicals Corporation Vinblastinesulphate (CAS 143-67-9) Type and Applications

Table Fine Chemicals Corporation Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Hengtengfu Biological Products Basic Information, Manufacturing Base and Competitors

Table Hengtengfu Biological Products Vinblastinesulphate (CAS 143-67-9) Type and Applications

Table Hengtengfu Biological Products Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Vinkem Basic Information, Manufacturing Base and Competitors

Table Vinkem Vinblastinesulphate (CAS 143-67-9) Type and Applications

Table Vinkem Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Vinblastinesulphate (CAS 143-67-9) Sales by Manufacturer (2016-2017)

Figure Global Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Manufacturer in 2016

Figure Global Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Manufacturer in 2017

Table Global Vinblastinesulphate (CAS 143-67-9) Revenue by Manufacturer (2016-2017)

Figure Global Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Manufacturer in 2016

Figure Global Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Manufacturer in 2017

Figure Top 3 Vinblastinesulphate (CAS 143-67-9) Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Vinblastinesulphate (CAS 143-67-9) Manufacturer (Revenue) Market Share in 2017

Figure Global Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Global Vinblastinesulphate (CAS 143-67-9) Revenue and Growth Rate (2013-2018)

Table Global Vinblastinesulphate (CAS 143-67-9) Sales by Regions (2013-2018)

Table Global Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Regions (2013-2018)

Table Global Vinblastinesulphate (CAS 143-67-9) Revenue by Regions (2013-2018)

Figure Global Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Regions in 2013

Figure Global Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Regions in 2017

Figure North America Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Europe Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure South America Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure North America Vinblastinesulphate (CAS 143-67-9) Revenue and Growth Rate (2013-2018)

Table North America Vinblastinesulphate (CAS 143-67-9) Sales by Countries (2013-2018)

Table North America Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Countries (2013-2018)

Figure North America Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Countries in 2013

Figure North America Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Countries in 2017

Table North America Vinblastinesulphate (CAS 143-67-9) Revenue by Countries (2013-2018)

Table North America Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Countries (2013-2018)

Figure North America Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Countries in 2013

Figure North America Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Countries in 2017

Figure United States Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Canada Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Mexico Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Europe Vinblastinesulphate (CAS 143-67-9) Revenue and Growth Rate (2013-2018)

Table Europe Vinblastinesulphate (CAS 143-67-9) Sales by Countries (2013-2018)

Table Europe Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Countries (2013-2018)

Table Europe Vinblastinesulphate (CAS 143-67-9) Revenue by Countries (2013-2018)

Figure Europe Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Countries in 2016

Figure Europe Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Countries in 2017

Figure Germany Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure UK Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure France Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Russia Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Italy Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Sales by Countries (2013-2018)

Table Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Countries 2017

Table Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Revenue by Countries (2013-2018)

Figure Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Countries 2017

Figure China Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Japan Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Korea Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure India Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Southeast Asia Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure South America Vinblastinesulphate (CAS 143-67-9) Revenue and Growth Rate (2013-2018)

Table South America Vinblastinesulphate (CAS 143-67-9) Sales by Countries (2013-2018)

Table South America Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Countries (2013-2018)

Figure South America Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Countries in 2017

Table South America Vinblastinesulphate (CAS 143-67-9) Revenue by Countries (2013-2018)

Table South America Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Countries (2013-2018)

Figure South America Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Countries in 2017

Figure Brazil Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Argentina Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Colombia Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Sales by Countries (2013-2018)

Table Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Countries in 2017

Table Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Revenue by Countries (2013-2018)

Table Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Countries in 2013

Figure Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Countries in 2017

Figure Saudi Arabia Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure UAE Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Egypt Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Nigeria Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure South Africa Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Table Global Vinblastinesulphate (CAS 143-67-9) Sales by Type (2013-2018)

Table Global Vinblastinesulphate (CAS 143-67-9) Sales Share by Type (2013-2018)

Table Global Vinblastinesulphate (CAS 143-67-9) Revenue by Type (2013-2018)

Table Global Vinblastinesulphate (CAS 143-67-9) Revenue Share by Type (2013-2018)

Figure Global >98% Vinblastinesulphate Sales Growth (2013-2018)

Figure Global >98% Vinblastinesulphate Price (2013-2018)

Figure Global 97-98% Vinblastinesulphate Sales Growth (2013-2018)

Figure Global 97-98% Vinblastinesulphate Price (2013-2018)

Figure Global Other Sales Growth (2013-2018)

Figure Global Other Price (2013-2018)

Table Global Vinblastinesulphate (CAS 143-67-9) Sales by Application (2013-2018)

Table Global Vinblastinesulphate (CAS 143-67-9) Sales Share by Application (2013-2018)

Figure Global Lung Cancer Sales Growth (2013-2018)

Figure Global Breast & Ovarian Cancer Sales Growth (2013-2018)

Figure Global Leukemia Sales Growth (2013-2018)

Figure Global Other Sales Growth (2013-2018)

Figure Global Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Growth Rate (2018-2023)

Table Global Vinblastinesulphate (CAS 143-67-9) Sales Forecast by Regions (2018-2023)

Table Global Vinblastinesulphate (CAS 143-67-9) Market Share Forecast by Regions (2018-2023)

Figure North America Sales Vinblastinesulphate (CAS 143-67-9) Market Forecast (2018-2023)

Figure Europe Sales Vinblastinesulphate (CAS 143-67-9) Market Forecast (2018-2023)

Figure Asia-Pacific Sales Vinblastinesulphate (CAS 143-67-9) Market Forecast (2018-2023)

Figure South America Sales Vinblastinesulphate (CAS 143-67-9) Market Forecast (2018-2023)

Figure Middle East and Africa Sales Vinblastinesulphate (CAS 143-67-9) Market Forecast (2018-2023)

Table Global Vinblastinesulphate (CAS 143-67-9) Sales Forecast by Type (2018-2023)

Table Global Vinblastinesulphate (CAS 143-67-9) Market Share Forecast by Type (2018-2023)

Table Global Vinblastinesulphate (CAS 143-67-9) Sales Forecast by Application (2018-2023)

Table Global Vinblastinesulphate (CAS 143-67-9) Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Licence Rights

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies


Companies

Guangzhou Hanfang Pharmaceutical

Hainan Vinca Biological Medicine Technology

Guangzhou Person Pharmaceutical

Hainan Yueyang Biotechnology

Hubei Honch Pharmaceutical

Fine Chemicals Corporation

Hengtengfu Biological Products

Vinkem

Company Profile

Company Profile Title

Vinblastinesulphate is a white or light yellow amorphous power, which is easily soluble in water. Vinblastine belongs to the group of cancer-fighting medications known as antineoplastics. Vinblastine is used alone or in combination with other antineoplastic medications to treat many different types of cancer including Hodgkin's disease, non-Hodgkin's lymphoma (cancer of the lymph cells), Kaposi's sarcoma, breast cancer, and testicular cancer. It kills cancer cells by interfering with the genetic material DNA, which is necessary for their growth and reproduction.

Scope of the Report:

This report focuses on the Vinblastinesulphate (CAS 143-67-9) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Periwinkle Plantation is mainly concentrated in China. The production volume was high during 2000s, with a kilo of Vinca alkaloids can be sold at 10 USD/gram. Now as the less plantation in Hainan Province, the cost of Periwinkle and Vinca alkaloids has hiked at 20 USD/ gram. Currenly there are less companies produce Vinca alkaloids, since many companies couldn't survive after capital chain breaks. Globally, leading suppliers are Guangzhou Hanfang Pharmaceutical, Hainan Vinca Biological Medicine Technology and Guangzhou Person Pharmaceutical which are located in China. The three companies produced nealy 60% of global Vinblastinesulphate Vinkem from India also produce Vinblastinesulphate API for cancer treatment drugs.

The worldwide market for Vinblastinesulphate (CAS 143-67-9) is expected to grow at a CAGR of roughly 1.6% over the next five years, will reach 21 million USD in 2023, from 19 million USD in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Guangzhou Hanfang Pharmaceutical

Hainan Vinca Biological Medicine Technology

Guangzhou Person Pharmaceutical

Hainan Yueyang Biotechnology

Hubei Honch Pharmaceutical

Fine Chemicals Corporation

Hengtengfu Biological Products

Vinkem

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

>98% Vinblastinesulphate

97-98% Vinblastinesulphate

Other

Market Segment by Applications, can be divided into

Lymphoma

Lung Cancer

Breast & Ovarian Cancer

Leukemia

Other

There are 15 Chapters to deeply display the global Vinblastinesulphate (CAS 143-67-9) market.

Chapter 1, to describe Vinblastinesulphate (CAS 143-67-9) Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Vinblastinesulphate (CAS 143-67-9), with sales, revenue, and price of Vinblastinesulphate (CAS 143-67-9), in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Vinblastinesulphate (CAS 143-67-9), for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Vinblastinesulphate (CAS 143-67-9) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Vinblastinesulphate (CAS 143-67-9) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

READ MORE

Scope

Table of Contents

1 Market Overview

1.1 Vinblastinesulphate (CAS 143-67-9) Introduction

1.2 Market Analysis by Type

1.2.1 >98% Vinblastinesulphate

1.2.2 97-98% Vinblastinesulphate

1.2.3 Other

1.3 Market Analysis by Applications

1.3.1 Lymphoma

1.3.2 Lung Cancer

1.3.3 Breast & Ovarian Cancer

1.3.4 Leukemia

1.3.5 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Guangzhou Hanfang Pharmaceutical

2.1.1 Business Overview

2.1.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Guangzhou Hanfang Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Hainan Vinca Biological Medicine Technology

2.2.1 Business Overview

2.2.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Hainan Vinca Biological Medicine Technology Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Guangzhou Person Pharmaceutical

2.3.1 Business Overview

2.3.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Guangzhou Person Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Hainan Yueyang Biotechnology

2.4.1 Business Overview

2.4.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Hainan Yueyang Biotechnology Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Hubei Honch Pharmaceutical

2.5.1 Business Overview

2.5.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Hubei Honch Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Fine Chemicals Corporation

2.6.1 Business Overview

2.6.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Fine Chemicals Corporation Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Hengtengfu Biological Products

2.7.1 Business Overview

2.7.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Hengtengfu Biological Products Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Vinkem

2.8.1 Business Overview

2.8.2 Vinblastinesulphate (CAS 143-67-9) Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Vinkem Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Vinblastinesulphate (CAS 143-67-9) Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Vinblastinesulphate (CAS 143-67-9) Manufacturer Market Share in 2017

3.3.2 Top 6 Vinblastinesulphate (CAS 143-67-9) Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Vinblastinesulphate (CAS 143-67-9) Market Analysis by Regions

4.1 Global Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Market Share by Regions

4.1.1 Global Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Regions (2013-2018)

4.1.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Regions (2013-2018)

4.2 North America Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

4.3 Europe Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

4.5 South America Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

5 North America Vinblastinesulphate (CAS 143-67-9) by Countries

5.1 North America Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Market Share by Countries

5.1.1 North America Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Countries (2013-2018)

5.1.2 North America Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Countries (2013-2018)

5.2 United States Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

5.3 Canada Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

5.4 Mexico Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

6 Europe Vinblastinesulphate (CAS 143-67-9) by Countries

6.1 Europe Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Market Share by Countries

6.1.1 Europe Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Countries (2013-2018)

6.2 Germany Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

6.3 UK Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

6.4 France Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

6.5 Russia Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

6.6 Italy Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

7 Asia-Pacific Vinblastinesulphate (CAS 143-67-9) by Countries

7.1 Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Countries (2013-2018)

7.2 China Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

7.3 Japan Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

7.4 Korea Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

7.5 India Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

8 South America Vinblastinesulphate (CAS 143-67-9) by Countries

8.1 South America Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Market Share by Countries

8.1.1 South America Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Countries (2013-2018)

8.1.2 South America Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

8.3 Argentina Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

8.4 Colombia Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

9 Middle East and Africa Vinblastinesulphate (CAS 143-67-9) by Countries

9.1 Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

9.3 UAE Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

9.4 Egypt Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

9.5 Nigeria Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

9.6 South Africa Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

10 Global Vinblastinesulphate (CAS 143-67-9) Market Segment by Type

10.1 Global Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Vinblastinesulphate (CAS 143-67-9) Sales and Market Share by Type (2013-2018)

10.1.2 Global Vinblastinesulphate (CAS 143-67-9) Revenue and Market Share by Type (2013-2018)

10.2 >98% Vinblastinesulphate Sales Growth and Price

10.2.1 Global >98% Vinblastinesulphate Sales Growth (2013-2018)

10.2.2 Global >98% Vinblastinesulphate Price (2013-2018)

10.3 97-98% Vinblastinesulphate Sales Growth and Price

10.3.1 Global 97-98% Vinblastinesulphate Sales Growth (2013-2018)

10.3.2 Global 97-98% Vinblastinesulphate Price (2013-2018)

10.4 Other Sales Growth and Price

10.4.1 Global Other Sales Growth (2013-2018)

10.4.2 Global Other Price (2013-2018)

11 Global Vinblastinesulphate (CAS 143-67-9) Market Segment by Application

11.1 Global Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Application (2013-2018)

11.2 Lymphoma Sales Growth (2013-2018)

11.3 Lung Cancer Sales Growth (2013-2018)

11.4 Breast & Ovarian Cancer Sales Growth (2013-2018)

11.5 Leukemia Sales Growth (2013-2018)

11.6 Other Sales Growth (2013-2018)

12 Vinblastinesulphate (CAS 143-67-9) Market Forecast (2018-2023)

12.1 Global Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Growth Rate (2018-2023)

12.2 Vinblastinesulphate (CAS 143-67-9) Market Forecast by Regions (2018-2023)

12.2.1 North America Vinblastinesulphate (CAS 143-67-9) Market Forecast (2018-2023)

12.2.2 Europe Vinblastinesulphate (CAS 143-67-9) Market Forecast (2018-2023)

12.2.3 Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Market Forecast (2018-2023)

12.2.4 South America Vinblastinesulphate (CAS 143-67-9) Market Forecast (2018-2023)

12.2.5 Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Market Forecast (2018-2023)

12.3 Vinblastinesulphate (CAS 143-67-9) Market Forecast by Type (2018-2023)

12.3.1 Global Vinblastinesulphate (CAS 143-67-9) Sales Forecast by Type (2018-2023)

12.3.2 Global Vinblastinesulphate (CAS 143-67-9) Market Share Forecast by Type (2018-2023)

12.4 Vinblastinesulphate (CAS 143-67-9) Market Forecast by Application (2018-2023)

12.4.1 Global Vinblastinesulphate (CAS 143-67-9) Sales Forecast by Application (2018-2023)

12.4.2 Global Vinblastinesulphate (CAS 143-67-9) Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source


List Of Figure

List of Tables and Figures

Figure Vinblastinesulphate (CAS 143-67-9) Picture

Table Product Specifications of Vinblastinesulphate (CAS 143-67-9)

Figure Global Sales Market Share of Vinblastinesulphate (CAS 143-67-9) by Types in 2017

Table Vinblastinesulphate (CAS 143-67-9) Types for Major Manufacturers

Figure >98% Vinblastinesulphate Picture

Figure 97-98% Vinblastinesulphate Picture

Figure Other Picture

Figure Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Applications in 2017

Figure Lymphoma Picture

Figure Lung Cancer Picture

Figure Breast & Ovarian Cancer Picture

Figure Leukemia Picture

Figure Other Picture

Figure United States Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Canada Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Mexico Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Germany Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure France Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure UK Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Russia Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Italy Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure China Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Japan Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Korea Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure India Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Southeast Asia Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Brazil Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Egypt Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Saudi Arabia Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure South Africa Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Figure Nigeria Vinblastinesulphate (CAS 143-67-9) Revenue (Value) and Growth Rate (2013-2023)

Table Guangzhou Hanfang Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Guangzhou Hanfang Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Type and Applications

Table Guangzhou Hanfang Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Hainan Vinca Biological Medicine Technology Basic Information, Manufacturing Base and Competitors

Table Hainan Vinca Biological Medicine Technology Vinblastinesulphate (CAS 143-67-9) Type and Applications

Table Hainan Vinca Biological Medicine Technology Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Guangzhou Person Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Guangzhou Person Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Type and Applications

Table Guangzhou Person Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Hainan Yueyang Biotechnology Basic Information, Manufacturing Base and Competitors

Table Hainan Yueyang Biotechnology Vinblastinesulphate (CAS 143-67-9) Type and Applications

Table Hainan Yueyang Biotechnology Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Hubei Honch Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table Hubei Honch Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Type and Applications

Table Hubei Honch Pharmaceutical Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Fine Chemicals Corporation Basic Information, Manufacturing Base and Competitors

Table Fine Chemicals Corporation Vinblastinesulphate (CAS 143-67-9) Type and Applications

Table Fine Chemicals Corporation Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Hengtengfu Biological Products Basic Information, Manufacturing Base and Competitors

Table Hengtengfu Biological Products Vinblastinesulphate (CAS 143-67-9) Type and Applications

Table Hengtengfu Biological Products Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Vinkem Basic Information, Manufacturing Base and Competitors

Table Vinkem Vinblastinesulphate (CAS 143-67-9) Type and Applications

Table Vinkem Vinblastinesulphate (CAS 143-67-9) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

Table Global Vinblastinesulphate (CAS 143-67-9) Sales by Manufacturer (2016-2017)

Figure Global Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Manufacturer in 2016

Figure Global Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Manufacturer in 2017

Table Global Vinblastinesulphate (CAS 143-67-9) Revenue by Manufacturer (2016-2017)

Figure Global Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Manufacturer in 2016

Figure Global Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Manufacturer in 2017

Figure Top 3 Vinblastinesulphate (CAS 143-67-9) Manufacturer (Revenue) Market Share in 2017

Figure Top 6 Vinblastinesulphate (CAS 143-67-9) Manufacturer (Revenue) Market Share in 2017

Figure Global Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Global Vinblastinesulphate (CAS 143-67-9) Revenue and Growth Rate (2013-2018)

Table Global Vinblastinesulphate (CAS 143-67-9) Sales by Regions (2013-2018)

Table Global Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Regions (2013-2018)

Table Global Vinblastinesulphate (CAS 143-67-9) Revenue by Regions (2013-2018)

Figure Global Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Regions in 2013

Figure Global Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Regions in 2017

Figure North America Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Europe Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure South America Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure North America Vinblastinesulphate (CAS 143-67-9) Revenue and Growth Rate (2013-2018)

Table North America Vinblastinesulphate (CAS 143-67-9) Sales by Countries (2013-2018)

Table North America Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Countries (2013-2018)

Figure North America Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Countries in 2013

Figure North America Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Countries in 2017

Table North America Vinblastinesulphate (CAS 143-67-9) Revenue by Countries (2013-2018)

Table North America Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Countries (2013-2018)

Figure North America Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Countries in 2013

Figure North America Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Countries in 2017

Figure United States Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Canada Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Mexico Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Europe Vinblastinesulphate (CAS 143-67-9) Revenue and Growth Rate (2013-2018)

Table Europe Vinblastinesulphate (CAS 143-67-9) Sales by Countries (2013-2018)

Table Europe Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Countries (2013-2018)

Table Europe Vinblastinesulphate (CAS 143-67-9) Revenue by Countries (2013-2018)

Figure Europe Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Countries in 2016

Figure Europe Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Countries in 2017

Figure Germany Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure UK Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure France Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Russia Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Italy Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Sales by Countries (2013-2018)

Table Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Countries (2013-2018)

Figure Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Countries 2017

Table Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Revenue by Countries (2013-2018)

Figure Asia-Pacific Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Countries 2017

Figure China Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Japan Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Korea Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure India Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Southeast Asia Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure South America Vinblastinesulphate (CAS 143-67-9) Revenue and Growth Rate (2013-2018)

Table South America Vinblastinesulphate (CAS 143-67-9) Sales by Countries (2013-2018)

Table South America Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Countries (2013-2018)

Figure South America Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Countries in 2017

Table South America Vinblastinesulphate (CAS 143-67-9) Revenue by Countries (2013-2018)

Table South America Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Countries (2013-2018)

Figure South America Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Countries in 2017

Figure Brazil Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Argentina Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Colombia Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Sales by Countries (2013-2018)

Table Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Countries (2013-2018)

Figure Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Sales Market Share by Countries in 2017

Table Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Revenue by Countries (2013-2018)

Table Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Countries in 2013

Figure Middle East and Africa Vinblastinesulphate (CAS 143-67-9) Revenue Market Share by Countries in 2017

Figure Saudi Arabia Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure UAE Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Egypt Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure Nigeria Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Figure South Africa Vinblastinesulphate (CAS 143-67-9) Sales and Growth Rate (2013-2018)

Table Global Vinblastinesulphate (CAS 143-67-9) Sales by Type (2013-2018)

Table Global Vinblastinesulphate (CAS 143-67-9) Sales Share by Type (2013-2018)

Table Global Vinblastinesulphate (CAS 143-67-9) Revenue by Type (2013-2018)

Table Global Vinblastinesulphate (CAS 143-67-9) Revenue Share by Type (2013-2018)

Figure Global >98% Vinblastinesulphate Sales Growth (2013-2018)

Figure Global >98% Vinblastinesulphate Price (2013-2018)

Figure Global 97-98% Vinblastinesulphate Sales Growth (2013-2018)

Figure Global 97-98% Vinblastinesulphate Price (2013-2018)

Figure Global Other Sales Growth (2013-2018)

Figure Global Other Price (2013-2018)

Table Global Vinblastinesulphate (CAS 143-67-9) Sales by Application (2013-2018)

Table Global Vinblastinesulphate (CAS 143-67-9) Sales Share by Application (2013-2018)

Figure Global Lung Cancer Sales Growth (2013-2018)

Figure Global Breast & Ovarian Cancer Sales Growth (2013-2018)

Figure Global Leukemia Sales Growth (2013-2018)

Figure Global Other Sales Growth (2013-2018)

Figure Global Vinblastinesulphate (CAS 143-67-9) Sales, Revenue and Growth Rate (2018-2023)

Table Global Vinblastinesulphate (CAS 143-67-9) Sales Forecast by Regions (2018-2023)

Table Global Vinblastinesulphate (CAS 143-67-9) Market Share Forecast by Regions (2018-2023)

Figure North America Sales Vinblastinesulphate (CAS 143-67-9) Market Forecast (2018-2023)

Figure Europe Sales Vinblastinesulphate (CAS 143-67-9) Market Forecast (2018-2023)

Figure Asia-Pacific Sales Vinblastinesulphate (CAS 143-67-9) Market Forecast (2018-2023)

Figure South America Sales Vinblastinesulphate (CAS 143-67-9) Market Forecast (2018-2023)

Figure Middle East and Africa Sales Vinblastinesulphate (CAS 143-67-9) Market Forecast (2018-2023)

Table Global Vinblastinesulphate (CAS 143-67-9) Sales Forecast by Type (2018-2023)

Table Global Vinblastinesulphate (CAS 143-67-9) Market Share Forecast by Type (2018-2023)

Table Global Vinblastinesulphate (CAS 143-67-9) Sales Forecast by Application (2018-2023)

Table Global Vinblastinesulphate (CAS 143-67-9) Market Share Forecast by Application (2018-2023)

Table Distributors/Traders/ Dealers List

Single User License - This is a single user license, allowing one specific user access to the product. The report will be emailed to you. The report is sent in PDF format.

Multi User License- allowing 1-20 people access to the product. The report will be emailed to you. The report is sent in PDF format and Excel Data. What's more, the comany can use the data, table, picture and figure on the report.

Corporate User License- This license will allow the entire company (Interface) to access the unlocked PDF version of this report without any restrictions. You can also take the print out if you wish toreceive the hard copy version of this report.

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS


Companies

Guangzhou Hanfang Pharmaceutical

Hainan Vinca Biological Medicine Technology

Guangzhou Person Pharmaceutical

Hainan Yueyang Biotechnology

Hubei Honch Pharmaceutical

Fine Chemicals Corporation

Hengtengfu Biological Products

Vinkem